Adagene (ADAG) Long-Term Debt Issuances (2019 - 2020)

Adagene's (ADAG) quarterly Long-Term Debt Issuances came in at $143583.0 in Q4 2020, up 205.15% year-on-year from $47054.0 in Q1 2020, and up 205.15% on a QoQ basis from $47054.0 in Q4 2019.

Adagene (ADAG) Long-Term Debt Issuances (2019 - 2020) Analysis & Trends

Adagene (ADAG) has 2 years of Long-Term Debt Issuances data on file, last reported at $143583.0 in Q4 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Issuances (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Adagene 198.85 Mn 198.85 Mn - -

Historic Data

Download Data
DateValue
Dec 31, 2020 143,583.00
Dec 31, 2020 143,583.00
Dec 31, 2019 47,054.00
Dec 31, 2019 47,054.00